Vaxil Bio Ltd. (TSXV:VXL)
Canada
· Delayed Price · Currency is CAD 0.160
0.00 (0.00%)
At close: Mar 6, 2026
Vaxil Bio Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 0.45 | 0.45 | 0.94 | 1.51 | 2.24 | 1.51 | Upgrade
|
| Cash & Short-Term Investments | 0.45 | 0.45 | 0.94 | 1.51 | 2.24 | 1.51 | Upgrade
|
| Cash Growth | -16.45% | -52.24% | -37.88% | -32.62% | 48.41% | 1719.28% | Upgrade
|
| Other Receivables | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.03 | Upgrade
|
| Receivables | 0.16 | 0.27 | 0.02 | 0.02 | 0.04 | 0.03 | Upgrade
|
| Prepaid Expenses | - | 0.01 | 0.02 | 0.01 | 0.01 | 0.09 | Upgrade
|
| Total Current Assets | 0.6 | 0.73 | 0.98 | 1.54 | 2.28 | 1.63 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0 | 0.03 | Upgrade
|
| Total Assets | 0.68 | 0.73 | 0.98 | 1.54 | 2.29 | 1.66 | Upgrade
|
| Accounts Payable | 0 | 0.01 | 0.08 | 0.39 | 0.56 | 0.57 | Upgrade
|
| Accrued Expenses | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | Upgrade
|
| Current Portion of Leases | - | - | - | - | - | 0.01 | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.26 | Upgrade
|
| Total Current Liabilities | 0.01 | 0.02 | 0.09 | 0.41 | 0.59 | 0.86 | Upgrade
|
| Total Liabilities | 0.01 | 0.02 | 0.09 | 0.41 | 0.59 | 0.86 | Upgrade
|
| Common Stock | 16.07 | 16.07 | 16.07 | 16.07 | 16.07 | 13.86 | Upgrade
|
| Retained Earnings | -19.58 | -19.54 | -19.36 | -19.1 | -18.52 | -17.53 | Upgrade
|
| Comprehensive Income & Other | 4.18 | 4.18 | 4.17 | 4.17 | 4.14 | 4.48 | Upgrade
|
| Shareholders' Equity | 0.67 | 0.72 | 0.89 | 1.14 | 1.7 | 0.8 | Upgrade
|
| Total Liabilities & Equity | 0.68 | 0.73 | 0.98 | 1.54 | 2.29 | 1.66 | Upgrade
|
| Total Debt | - | - | - | - | - | 0.01 | Upgrade
|
| Net Cash (Debt) | 0.45 | 0.45 | 0.94 | 1.51 | 2.24 | 1.5 | Upgrade
|
| Net Cash Growth | -16.45% | -52.24% | -37.88% | -32.62% | 49.30% | 16577.78% | Upgrade
|
| Net Cash Per Share | 0.16 | 0.16 | 0.34 | 0.55 | 0.82 | 0.74 | Upgrade
|
| Filing Date Shares Outstanding | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.73 | Upgrade
|
| Total Common Shares Outstanding | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.38 | Upgrade
|
| Working Capital | 0.6 | 0.72 | 0.89 | 1.14 | 1.7 | 0.78 | Upgrade
|
| Book Value Per Share | 0.24 | 0.26 | 0.33 | 0.41 | 0.62 | 0.34 | Upgrade
|
| Tangible Book Value | 0.67 | 0.72 | 0.89 | 1.14 | 1.7 | 0.8 | Upgrade
|
| Tangible Book Value Per Share | 0.24 | 0.26 | 0.33 | 0.41 | 0.62 | 0.34 | Upgrade
|
| Machinery | - | - | - | - | 0.21 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.